Ontology highlight
ABSTRACT:
SUBMITTER: Poole CD
PROVIDER: S-EPMC4094440 | biostudies-literature | 2014 Jun
REPOSITORIES: biostudies-literature
Poole Chris D CD Bannister Christian A CA Andreasen Jakob Nørgaard JN Andersen Jens Strodl JS Currie Craig J CJ
Health and quality of life outcomes 20140613
<h4>Background</h4>Grass allergen immunotherapy (AIT) reduces symptom severity in seasonal allergic rhinoconjunctivitis (ARC) but its impact on general health-related utility has not been characterised for the purposes of economic evaluation. The aim of this study was to model the preferred measure of utility, EQ-5D index, from symptom severity and estimate incremental quality adjusted life years (QALYs) associated with SQ-standardised grass immunotherapy tablet (GRAZAX®, 75,000 SQ-T/2,800 BAU, ...[more]